Page updated: 15 Mar 2026
Costello Medical
·Rank 26
Costello Medical provides carbon accounting, life cycle assessment consulting, and decarbonization technology services, with specialization in the pharmaceuticals, biotechnology, and life sciences sector. The company holds SBTi Target Validation with a 1.5°C emissions reduction target and a net-zero commitment for FY2050. Based in the United Kingdom, Costello Medical supports organizations in developing and implementing science-based decarbonization strategies.
Company Overview
Active in carbon accounting, life cycle assessment and sustainability consulting, science-based emissions reduction targets and industrial decarbonization technology within the UK energy and sustainability sector.
Market Context
UK companies follow the Streamlined Energy and Carbon Reporting (SECR) framework alongside evolving sustainability disclosure standards.
Company Details
| Company Name | Costello Medical |
| Country | 🇬🇧 United Kingdom |
| Website | www.costellomedical.co.uk |
| Sector | Carbon Accounting & Industrial Decarbonization |
Classification
Specializations: Pharmaceuticals, Biotechnology and Life Sciences
Certifications: SBTi Target Validated · Target: 1.5°C · Net-Zero: FY2050
About This Listing
Costello Medical is included in this directory because it is classified under carbon accounting based on business activity, and maintains an active company website.
Information on this page is compiled from public business registers and industry databases. If you represent this company and would like to update or expand this listing, use the "Claim Listing" option.
Similar Companies